CircRNA-ST6GALNAC6 Increases the Sensitivity of Bladder Cancer Cells to Erastin-induced Ferroptosis by Regulating the HSPB1/P38 Axis

Overview

Journal Lab Invest

Specialty Pathology

Date 2022 Aug 9

PMID 35945269

Authors

Li Wang

Shuiqing Wu

Haiqing He

Kai Ai

Ran Xu

Lei Zhang

Xuan Zhu

Affiliations

Soon will be listed here.

Abstract

Previous studies have demonstrated that circST6GALNAC6 is a tumor suppressor in bladder cancer. However, the role of circST6GALNAC6 in ferroptosis remains unclear. In the current study, ferroptosis was induced in bladder cancer cells by erastin. Functional experiments showed that overexpression of circST6GALNAC6 promoted ferroptosis of bladder cancer cells in vitro and in vivo. Mechanistic studies revealed that circST6GALNAC6 bound to the N-terminus of small heat shock protein 1 (HSPB1) and thus blocked the erastin-induced phosphorylation of HSPB1 at the Ser-15 site, a phosphorylation site in the protective response to ferroptosis stress. In addition, protein kinase C inhibited circST6GALNAC6-induced ferroptosis by increasing the overall phosphorylation level of HSPB1, further demonstrating the role of phosphorylation activation of HSPB1 in resistance to ferroptosis. Finally, the involvement of the HSPB1/p38 MAPK pathway in the downstream signal transduction of circST6GALNAC6 in bladder cancer ferroptosis regulation was determined. The regulatory mechanism of ferroptosis sensitivity dependent on circST6GALNAC6 expression levels in bladder cancer was revealed as circRNA regulation of various protein functions. CircST6GALNAC6 inhibits HSPB1 and promotes cell ferroptosis by occupying the phosphorylation site (Ser-15) of HSBP1 and activating the P38 MAPK signaling pathway. Therefore, enhancing the expression of circST6GALNAC6 to promote ferroptosis or using circST6GALNAC6 as a biomarker of ferroptosis sensitivity is of considerable importance to the development and application of ferroptosis intervention methods in bladder cancer.

Citing Articles

Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment.

Rostami Ravari N, Sadri F, Mahdiabadi M, Mohammadi Y, Ourang Z, Rezaei Z Front Cell Dev Biol. 2025; 13:1522873.

PMID: 40078365 PMC: 11897296. DOI: 10.3389/fcell.2025.1522873.

Regulation of ferroptosis in osteoarthritis and osteoarthritic chondrocytes by typical MicroRNAs in chondrocytes.

Yu Q, Xiao Y, Guan M, Zhou G, Zhang X, Yu J Front Med (Lausanne). 2024; 11:1478153.

PMID: 39564502 PMC: 11573538. DOI: 10.3389/fmed.2024.1478153.

Critical role of non-coding RNA-mediated ferroptosis in urologic malignancies.

Li W, Zheng L, Luo P, Chen T, Zou J, Chen Q Front Immunol. 2024; 15:1486229.

PMID: 39544949 PMC: 11560455. DOI: 10.3389/fimmu.2024.1486229.

Mechanisms of ferroptosis and targeted therapeutic approaches in urological malignancies.

Ma W, Jiang X, Jia R, Li Y Cell Death Discov. 2024; 10(1):432.

PMID: 39384767 PMC: 11464522. DOI: 10.1038/s41420-024-02195-w.

Unveiling the functional roles of patient-derived tumour organoids in assessing the tumour microenvironment and immunotherapy.

Chen D, Xu L, Xuan M, Chu Q, Xue C Clin Transl Med. 2024; 14(9):e1802.

PMID: 39245957 PMC: 11381553. DOI: 10.1002/ctm2.1802.

References

Siegel R, Miller K, Fuchs H, Jemal A . Cancer Statistics, 2021. CA Cancer J Clin. 2021; 71(1):7-33. DOI: 10.3322/caac.21654. View

Abdollah F, Gandaglia G, Thuret R, Schmitges J, Tian Z, Jeldres C . Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis. Cancer Epidemiol. 2013; 37(3):219-25. DOI: 10.1016/j.canep.2013.02.002. View

Kong N, Chen X, Feng J, Duan T, Liu S, Sun X . Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1. Acta Pharm Sin B. 2022; 11(12):4045-4054. PMC: 8727776. DOI: 10.1016/j.apsb.2021.03.036. View

Hsu M, Coca-Prados M . Electron microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells. Nature. 1979; 280(5720):339-40. DOI: 10.1038/280339a0. View

Cocquerelle C, Mascrez B, Hetuin D, Bailleul B . Mis-splicing yields circular RNA molecules. FASEB J. 1993; 7(1):155-60. DOI: 10.1096/fasebj.7.1.7678559. View

Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A . Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013; 495(7441):333-8. DOI: 10.1038/nature11928. View

Rybak-Wolf A, Stottmeister C, Glazar P, Jens M, Pino N, Giusti S . Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed. Mol Cell. 2015; 58(5):870-85. DOI: 10.1016/j.molcel.2015.03.027. View

Lei M, Zheng G, Ning Q, Zheng J, Dong D . Translation and functional roles of circular RNAs in human cancer. Mol Cancer. 2020; 19(1):30. PMC: 7023758. DOI: 10.1186/s12943-020-1135-7. View

Li C, Tian Y, Liang Y, Li Q . Circ_0008035 contributes to cell proliferation and inhibits apoptosis and ferroptosis in gastric cancer via miR-599/EIF4A1 axis. Cancer Cell Int. 2020; 20(1):84. PMC: 7076943. DOI: 10.1186/s12935-020-01168-0. View

10.

Zhang H, Zhang B, Zhang Z, Deng Q . Circular RNA TTBK2 regulates cell proliferation, invasion and ferroptosis via miR-761/ITGB8 axis in glioma. Eur Rev Med Pharmacol Sci. 2020; 24(5):2585-2600. DOI: 10.26355/eurrev_202003_20528. View

11.

Zhang H, Ge Z, Wang Z, Gao Y, Wang Y, Qu X . Circular RNA RHOT1 promotes progression and inhibits ferroptosis via mir-106a-5p/STAT3 axis in breast cancer. Aging (Albany NY). 2021; 13(6):8115-8126. PMC: 8034942. DOI: 10.18632/aging.202608. View

12.

Tan S, Kang Y, Li H, He H, Zheng L, Wu S . circST6GALNAC6 suppresses bladder cancer metastasis by sponging miR-200a-3p to modulate the STMN1/EMT axis. Cell Death Dis. 2021; 12(2):168. PMC: 7876104. DOI: 10.1038/s41419-021-03459-4. View

13.

Saini J, Sharma P . Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in Cancer. Curr Drug Targets. 2017; 19(13):1478-1490. DOI: 10.2174/1389450118666170823121248. View

14.

Takayama S, Reed J, Homma S . Heat-shock proteins as regulators of apoptosis. Oncogene. 2003; 22(56):9041-7. DOI: 10.1038/sj.onc.1207114. View

15.

Rogalla T, Ehrnsperger M, Preville X, Kotlyarov A, LUTSCH G, Ducasse C . Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J Biol Chem. 1999; 274(27):18947-56. DOI: 10.1074/jbc.274.27.18947. View

16.

Sun X, Ou Z, Xie M, Kang R, Fan Y, Niu X . HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene. 2015; 34(45):5617-25. PMC: 4640181. DOI: 10.1038/onc.2015.32. View

17.

Kamada M, So A, Muramaki M, Rocchi P, Beraldi E, Gleave M . Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells. Mol Cancer Ther. 2007; 6(1):299-308. DOI: 10.1158/1535-7163.MCT-06-0417. View

18.

Wada T, Penninger J . Mitogen-activated protein kinases in apoptosis regulation. Oncogene. 2004; 23(16):2838-49. DOI: 10.1038/sj.onc.1207556. View

19.

Arthur J, Ley S . Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol. 2013; 13(9):679-92. DOI: 10.1038/nri3495. View

20.

Chang W, Bow Y, Fu P, Li C, Wu C, Chang Y . A Marine Terpenoid, Heteronemin, Induces Both the Apoptosis and Ferroptosis of Hepatocellular Carcinoma Cells and Involves the ROS and MAPK Pathways. Oxid Med Cell Longev. 2021; 2021:7689045. PMC: 7803406. DOI: 10.1155/2021/7689045. View